Sialuria
Symptoms, Doctors, Treatments, Advances & More

Learn About Sialuria

What is the definition of Sialuria?

Sialuria is a rare disorder that affects development. Infants with sialuria are often born with a yellow tint to the skin and the whites of the eyes (neonatal jaundice), an enlarged liver and spleen (hepatosplenomegaly), and unusually small red blood cells (microcytic anemia). They may develop a somewhat flat face and distinctive-looking facial features that are described as "coarse." Temporarily delayed development and weak muscle tone (hypotonia) have also been reported.

What are the causes of Sialuria?

Variants (also called mutations) in the GNE gene cause sialuria. The GNE gene provides instructions for making an enzyme found in cells and tissues throughout the body. This enzyme is involved in a chemical pathway that produces sialic acid, which is a simple sugar that attaches to the ends of more complex molecules on the surface of cells. By modifying these molecules, sialic acid influences a wide variety of cellular functions, including cell movement (migration), the attachment of cells to one another (adhesion), signaling between cells, and inflammation.

How prevalent is Sialuria?

Fewer than 20 cases of sialuria have been described worldwide. There are probably more people with the disorder who have not been diagnosed, as sialuria can be difficult to detect because of its variable features.

Is Sialuria an inherited disorder?

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Most reported cases have occurred in people with no known history of the disorder in their family. These cases may represent new (de novo) variants in the gene that occur during the formation of reproductive cells (eggs or sperm) in an affected individual's parent or during early embryonic development.

Who are the top Sialuria Local Doctors?
Advanced in Sialuria
Internal Medicine
Advanced in Sialuria
Internal Medicine

University Hospitals Samaritan Medical Center

1025 Center St, 
Ashland, OH 
Languages Spoken:
English, Farsi
Accepting New Patients
Offers Telehealth

Mehrdad Tavallaee is a primary care provider, practicing in Internal Medicine in Ashland, Ohio. Dr. Tavallaee is rated as an Advanced provider by MediFind in the treatment of Sialuria. He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Type 2 Diabetes (T2D). Dr. Tavallaee is currently accepting new patients.

Advanced in Sialuria
Internal Medicine
Advanced in Sialuria
Internal Medicine

Office

2021 S Baney Rd Ste A, 
Ashland, OH 
Languages Spoken:
English, Farsi, Fijian
Accepting New Patients
Offers Telehealth

Faranak Zarrabi is a primary care provider, practicing in Internal Medicine in Ashland, Ohio. Dr. Zarrabi is rated as an Advanced provider by MediFind in the treatment of Sialuria. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Phosphomannoisomerase Deficiency, PMM2-Congenital Disorder of Glycosylation, Sialuria, and Sialic Acid Storage Disease. Dr. Zarrabi is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Sialuria
Family Medicine
Experienced in Sialuria
Family Medicine

Texas Health Family Care

7001 Granbury Road, 
Fort Worth, TX 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Alfred Hulse is a primary care provider, practicing in Family Medicine in Fort Worth, Texas. Dr. Hulse is rated as an Experienced provider by MediFind in the treatment of Sialuria. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Sitosterolemia, High Cholesterol, Type 2 Diabetes (T2D), and Infant Hyperglycemia. Dr. Hulse is currently accepting new patients.

What are the latest Sialuria Clinical Trials?
The Myelin Disorders Biorepository Project and Global Leukodystrophy Initiative Clinical Trials Network

Summary: The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest leukodystrophy biorepositories, having enrolled nearly 2,000 affected individuals since it was launched over a decade ago. Researchers working in the biorepo...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: March 06, 2024
Published By: National Institutes of Health